Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LISINOPRIL DIHYDRATE, USP, with a corresponding US DMF Number 14801.
Remarkably, this DMF maintains an Active status since its submission on March 24, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2013, and payment made on March 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II